StockClub

ATNM

ATNMActinium Pharmaceuticals, Inc.$ --
Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc.

ATNM

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-6M USD
YoY +64.5%
Net Income
-6M USD
YoY +65.4%
EPS
-0.18$
YoY +64.7%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$90,000
$90,000
Q3
FY2025 Q4$90,000
$90,000
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-5.5M
FY2024 Q2$-20M
$-20M
Q2
FY2024 Q3$-31.6M
$-31.6M
Q3
FY2024 Q4$-38.2M
$-38.2M
Q4
FY2025 Q1$-15.9M
$-15.9M
Q1
FY2025 Q2$-22.8M
$-22.8M
Q2
FY2025 Q3$-27.9M
$-27.9M
Q3
FY2025 Q4$-33.9M
$-33.9M
Q4
FY2026 Q1$-5.5M
$-5.5M
Q1
Actual
+$10.4M (+65.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021MISS
Actual:$1.1M
Est:$1.2M
FY2021MISS
$1.1M
FY2022BEAT
Actual:$1M
Est:$1M
FY2022BEAT
$1M
FY2023IN-LINE
Actual:$81,000
Est:$81,000
FY2023IN-LINE
$81,000
FY2024MISS
Actual:$0
Est:$42,525
FY2024MISS
$0
FY2025IN-LINE
Actual:$90,000
Est:$90,000
FY2025IN-LINE
$90,000

Analyst Estimates